Top 50 Life Science Startup Investors in Germany in November 2024
A list of 50 angel investors and VC (Venture Capital) funds that invest in Life science startups based in Germany. We rank investors based on the number of investments they made in Life science companies from Germany. We update this investor list every month.Top 50 Life Science Startup Investors in Germany in November 2024
Investor | Life Science Germany investments |
---|---|
HTGF | High-Tech Gruenderfonds | 5 |
IFB Innovationsstarter | 5 |
coparion | 5 |
CPT Capital | 3 |
Lima Ventures | 3 |
Agronomics | 3 |
Elevat3 Capital | 3 |
Lowercarbon Capital | 3 |
Andrew Keys | 3 |
Grazia Equity | 3 |
Good Seed Ventures | 3 |
Carsten Maschmeyer | 2 |
Lionheart Ventures | 2 |
Thor Bjorgolfsson | 2 |
Happiness Capital | 2 |
Holger Hübner | 2 |
Ananda Impact Ventures | 2 |
Die Brückenköpfe | 2 |
KfW | 2 |
Mike Novogratz | 2 |
Shine Capital | 2 |
EQT Group | 2 |
M Ventures | 2 |
Albert Wenger | 2 |
1kx | 2 |
AQAL Integral Investing | 2 |
Inflection.xyz | 2 |
Amino Collective | 2 |
Boehringer Ingelheim Venture Fund | 2 |
IBB Ventures | 2 |
Nico Wittenborn | 2 |
Cherry Ventures | 1 |
Abiomed | 1 |
Healthspan Capital | 1 |
TechVision Fund | 1 |
Bool Capital | 1 |
Nimble Ventures | 1 |
Brightlands Venture Partners | 1 |
KdT Ventures | 1 |
Orange DAO | 1 |
Think.Health | 1 |
Teknoloji Yatirim | 1 |
Qiagen | 1 |
Iduskia | 1 |
b.value AG | 1 |
hiVC | 1 |
Chris Leiter | 1 |
BACKED VC | 1 |
Chorus One | 1 |
Seed Fonds Aachen | 1 |
The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise,entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.
Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.
Show more
Investment focus
- Software, Information Technology, Biotechnology
- Seed, Series A, Funding Round
- Germany, Switzerland, United States
Portfolio highlights
- Nuuron — Nuuron is a neurotech startup that is developing the Memory-Pacemaker, a non-invasive photonic neurostimulation device that allows Alzheimer's sufferers to store and retrieve memories anew.
- GlassFlow — GlassFlow is a serverless and production-ready setup that empowers everyone in your data team to build and transform event-based pipelines in minutes.
- Cloudsquid — is an an artificial intelligence based revenue orchestration company intended for companies with usage-based pricing models.
The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments.
Show more
Investment focus
- Software, SaaS, Artificial Intelligence
- Seed, Funding Round, Grant
- Germany, United States
Portfolio highlights
- 3D Spark — Profitability and Sustainability Aligned using 3D Spark's Platform - Empowering Manufacturing with Insights and Efficiency!
- Tomorrow — Tomorrow combines mobile banking with sustainability. Open your sustainable account in minutes & start protecting the climate right away.
- Neuralfinity — Neuralfinity provides computer AI services. They generalise machine learning models by utilising an ML API as a service.
Coparion provides venture capital to accelerate momentum and growth. With a currently active fund of EUR 275 million, Coparion has the means to do so.Coparion supports entrepreneurial vision with know-how, but without intervening in daily business operations. Thanks to in-depth experience in venture capital and in building companies, the Coparionteam discerns potential and opens up new perspectives. Coparion has the substance, tenacity, and creativity required to mutually manage difficult situations successfully.Coparion only invests with co-investors. The fund invests up to EUR 15M per company, usually in several financing rounds of EUR 0.5-8M each. The investment focus is on German companies in the start-up and early growth phases. Coparion is based in Cologne and Berlin.
Show more
Investment focus
- Software, SaaS, FinTech
- Series A, Seed, Series B
- Germany, Switzerland, United States
Portfolio highlights
- Finoa — Finoa is the leading European crypto-asset management platform, empowering businesses and institutions to engage with crypto safely and intuitively.
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.
Show more
Investment focus
- Food and Beverage, Food Processing, Biotechnology
- Series A, Seed, Series B
- United States, Israel, United Kingdom
Portfolio highlights
- ENOUGH — ENOUGH makes protein sustainable by producing ABUNDA mycoprotein, made by fermenting fungi with the natural sugars from grains. It is a whole protein with all 9 essential amino acids & rich in fibre. It is a B2B ingredient, neutral in taste and fibrous in texture, like meat. The most sustainable
- PoLoPo — PoLoPo is a biotech company that produces proteins on a large scale and according to specifications. PoLoPo develops a "superAA" plant by employing directed metabolic engineering techniques and fully utilizing plants' capacity as various metabolite and green protein factories. A significant amount of free amino acids can be producedby the superAA. The increased production of amino acids is then translated into an increase in the scale at which proteins are produced in plant organs.
- Wanda Fish Technologies — Wanda Fish is an innovative FoodTech company with a platform that produces a wide variety of delicious fish fillets using sustainable cell-cultivation practices.
Collaboration with outstanding initiators with exceptional insights, from inception through all levels of progress. Lima Ventures supports visionary founders as well as provides certain services to early startups. We seek innovative technology-driven entrepreneurs who generate and lead companies that will inspire millions.
Show more
Investment focus
- Artificial Intelligence, Software, Digital Marketing
- Seed, Pre-Seed, Funding Round
- Turkey, United Kingdom, Estonia
Portfolio highlights
- heybooster — Heybooster is a provider of analytical tools to ecommerce companies to take better digital marketing decisions.
- Mars Studios — Mars Studios is an experienced team of growth hackers & marketers that can help you to increase your revenue. Rocket Your App to Success: Mars Studios
- Enqura Information Technologies — Enqura Information Technologies offers advanced technologies in conjunction with human resources as reasonable solutions. Enqura develops creative solutions in the field of digital transformation. They provide innovative and end-to-end solutions to several industries, primarily finance and insurance.
Venture capital investment can raise funds for your small business. Venture Capital Firms in the UK like Agronomics is a biotech venture capital firm which invest into the clean meat sector.
Show more
Investment focus
- Biotechnology, Food and Beverage, Food Processing
- Seed, Series A, Series B
- United States, Finland, Germany
Portfolio highlights
- GALY — Saving Our Planet by Transitioning the World to Cellular Agriculture
- Onego Bio — Onego Bio is a cell ag company, specialized in animal-free egg white protein. We produce bioalbumen with an innovative precision fermentation process.
- Liberation Labs — Liberation Labs believe that by innovating technology, It can free the world from the costs of industrialized agriculture and unlock a new era of accessible, healthy foods. The mission is to make precision fermentation by commercializing purpose-built manufacturing facilities for industrial biotech.
Elevat3 Capital is the venture capital arm of serial entrepreneur and investor Christian Angermayer and his family office Apeiron Investment Group. With a focus on German-speaking countries, we partner with companies that meet our three-level criteria, then elevate them by providing more than just capital. We use our exceptional network, spanningindustry, politics, arts, science and technology, to give our portfolio companies access to high-profile leads and advisors, enabling them to grow rapidly and achieve amazing results.
Show more
Investment focus
- FinTech, Apps, Life Science
- Series A, Series B, Post-IPO Equity
- Germany, United Kingdom
Portfolio highlights
- Formo — We're Formo, the future of dairy. Using micro fermentation, we create animal-free cheeses that humans love.
- Naga — NAGA is disrupting the worlds of trading and investment by making them more open and inclusive. It is the single solution that's got it all: Trade, Earn, Invest, Acquire, Connect, Pay; all in one seamless and unified ecosystem that is radically social! Traders and investors from all around the world can use the NAGA technology every day inmany powerful ways: invest in the financial markets (physical stocks, CFDs in stocks, indices, currencies, energies, metals, commodities and cryptocurrencies), make payments in fiat and cryptocurrency, learn about wealth as well as communicate and connect with like-minded people anywhere and anytime. NAGA expands the one-of-a-kind experience with many other unique and innovative services such as the NAGA Mastercard, the AI-driven Portfolio baskets, the world’s first messenger where traders can exchange ideas and opinions in its public channels, Auto-Copying other traders and copying trading signals thanks to the revolutionary NAGA Signals feature.NAGA is really greater than the sum of its parts and powerful when its full spectrum of products and features are used together.
- Legendairy Foods — We're Formo, the future of dairy. Using micro fermentation, we create animal-free cheeses that humans love.
Lowercarbon Capital backs kickass companies slashing CO2 emissions, sucking carbon out of the sky, and buying us time to unf**k the planet.
Show more
Investment focus
- Biotechnology, Renewable Energy, Energy
- Seed, Series A, Series B
- United States, United Kingdom, France
Portfolio highlights
- Storio Energy — Storio Energy is an AI-powered energy efficiency technology platform that provides renewable energy.
- Pacific Fusion — Pacific Fusion was founded in 2023 with the mission to power the world with abundant, affordable, clean energy.
- Matter Intelligence — Matter Intelligence is creating the most detailed map of the world using first-of-a-kind sensors to understand our planet like never before
Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.
Show more
Investment focus
- Software, Finance, Blockchain
- Seed, Pre-Seed, Series A
- United States, India, Norway
Portfolio highlights
- Stackr Labs — Micro-rollups to scale web3 applications
- Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
- Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Grazia Equity is a venture Capital firm investing in innovative, technology driven startups with high potential.Based in Stuttgart (Germany), Grazia has been supporting a large number of mostly young companies, often from their foundation to the Initial Public Offering or eventual sale.
In contrast to other venture capital firms, theypredominantly work with their own capital that they invest as entrepreneurs.
Show more
Investment focus
- Internet, E-Commerce, Biotechnology
- Series A, Seed, Series B
- Germany, United States, Switzerland
Portfolio highlights
- ZAGENO — ZAGENO is a multi-vendor, online marketplace of life science products which, by simplifying the procurement process, saves more time for science.
- XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
- Formo — We're Formo, the future of dairy. Using micro fermentation, we create animal-free cheeses that humans love.
Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.
Show more
Investment focus
- Food and Beverage, Food Processing, Biotechnology
- Seed, Series A, Pre-Seed
- Germany, Israel, United States
Portfolio highlights
- Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
- Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
- Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.
Carsten Maschmeyer is a successful entrepreneur, consultant and financial investor. He was born on May 8, 1959 in Bremen and grew up in Hildesheim. After his graduation in 1978 Maschmeyer completed military service before he began to study medicine in Hannover. To finance his studies, he worked part-time in sales of investment advice to it in 1982completely dedicated financial advice. More about Carsten Masch Meyers consultant. In 1988 Carsten Maschmeyer to AWD financial group, which was successfully launched on the stock market in 2000 and rise to the MDAX and expanded in 11 countries. Was sold in 2007 Carsten Maschmeyer all his shares in the company at the insurance group Swiss Life, who renamed the AWD in AWD Holding. Maschmeyer has today different occupational focuses, inter alia, as entrepreneur, investor and consultant. His experience Carsten Maschmeyer a sought-after speaker on the subject of success. Motivated by the desire expressed by many listeners to learn more about his secret of success, Carsten Maschmeyer published in the spring of 2012 his book "Self Made - performance live richly". In it he describes the basis of his own exciting path and the celebrities strategies for professional, financial and personal success.
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Angel, Series A
- Germany, Austria, Switzerland
Portfolio highlights
- Zeedz — Gaming for a green future. Zeedz is a monster collectible game that targets real-world climate change. Discover a world of plantified magic, made in Berlin.
- theblood — We are giving back self-determination, control and specific health conditions to our users through a non-invasive menstrual blood test
- JobSwop.io — JobSwop.io is the employment software that allows you to find available positions but also filled ones for people looking to move jobs. The features of this app are Salary information, a Watch list, Area search, Integrated chat, Up to three Job profiles in one account, Document management.
Lionheart Ventures is a global, seed-stage venture capital firm investing in companies that make humanity more resilient.
Show more
Investment focus
- Health Care, Wellness, Biotechnology
- Seed, Series A, Funding Round
- United States, United Kingdom, Singapore
Portfolio highlights
- Psylo — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
- Momentu — Corporate mental health and emotional wellness platform for Latin America
- Clerkenwell Health — Clerkenwell Health addresses the growing unmet demand for effective mental health treatments.
Thor Bjorgolfsson - Entrepreneur, Businessman and Adventure Capitalist Thor Bjorgolfsson, Iceland’s first and only current billionaire, is an investor and business innovator who is not afraid of risk. He has been an entrepreneur since childhood, making his first deal at the age of 10, when he purchased a stack of vintage Marvel comics withborrowed money.In 2004, he founded Novator Partners, an alternative investment firm. He has strategically developed the company to allow it to maintain maximum flexibility as well as to facilitate investments in both strategic (buy and hold) and financial (buy and exit) opportunities.With Novator, Thor leverages private equity as well as macro investments and manages assets across a variety of sectors and geographic locations. He is an active investor in emerging economies including Central and Eastern Europe as well as Latin America.Novator Partners has been a major player in telecom businesses. Thor is a stakeholder in a Polish telecom company called Play, which went public in 2017. In addition, he holds shares in WOM, a Chilean telecommunications firm.Bjorgolfsson’s first fortune was made in post-soviet Russia. At a time when others perceived Russia to be tumultuous, he saw an underserved market that presented an exciting opportunity to invest in great ideas and businesses. He co-founded and developed Bravo Brewery, which produced beer and alcopops. Bravo became one of Russia’s premier brewing companies, particularly through its popular Botchkarov beer brand. Thor sold the business in 2002 to Heineken for $100 million.With the sale of Bravo, he was able to diversify his holdings by reinvesting in new ventures, focusing on telecommunications, pharmaceuticals, and banks. In a few years, he was able to turn that $100 million into a net worth of over $2.1 billion.A year after being featured on the 2007 cover of Forbes Magazine, Iceland went nearly bankrupt overnight and Thor found himself at the epicenter of the financial crisis. As a major shareholder in Landsbanki with personal guarantees of 350m euro, he refused to declare bankruptcy and eventually succeeded in paying off all of it. He then went on to invest in new businesses, re-establishing himself and being featured on the Forbes list of billionaires once again.During this time of rejuvenation, he wrote Billions to Bust and Back: How I Made, Lost and Rebuilt a Fortune, And What I Learned on the Way (2014). In the book, he shares his perspective of what it was like to be at the center of the storm and how he made it back to financial success. He proposes that the greatest strength an entrepreneur can possess is a positive attitude.The 52-year-old Thor was educated in the United States where he earned a Bachelor of Science degree from New York University. In 2005, he was honored as a Young Global Leader by the World Economic Forum. In spite of his intense schedule, Thor enjoys sharing his experience and business insight, making him a sought-after speaker. A multilingual Icelandic citizen, Thor spends most of his time in London, living with his wife and three children. Thor's personal passion is his collection of six motorcycles, which he rides whenever time permits.
Show more
Investment focus
- Big Data, TV, TV Production
- Seed, Series A, Series C
- United Kingdom, Germany
Portfolio highlights
- Olvin — Olvin helps reactive real-world businesses get ahead of the curve and become proactive through the use of its AI powered, predictive analytics platform. Harnessing billions of real world data points, from events and precise location, through to weather and points of interest, Olvin's advanced neural network identifies patterns. Through theuse of both probabilistic and deterministic scoring, Olvin's AI provides actionable insights to brands, retailers and businesses to give them an unparalleled opportunity to delight their customers, identify opportunities and get ahead of potential threats.
- DNEG — We are DNEG, one of the world's leading visual effects and animation studios for feature film and television, honoured with the Academy Award six times
- ATAI Life Sciences — ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. The company is committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in themental health space.ATAI Life Sciences was founded in 2018 and is based in Munich, Bayern, Germany.
We invest in startups and VC funds that share our values across crucial sectors for the planet backed by a global network of entrepreneurs and scientists working towards a happier future
Show more
Investment focus
- Food and Beverage, Biotechnology, AgTech
- Seed, Series A, Series B
- Germany, United States, Israel
Portfolio highlights
- Formo — We're Formo, the future of dairy. Using micro fermentation, we create animal-free cheeses that humans love.
- Gozen — Transforming our material world. We create advanced biomaterials to unlock earth-centric design.
- Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
Holger Hübner
Show more
Investment focus
- B2B, SaaS, Audio
- Seed, Pre-Seed
- Germany
Portfolio highlights
- musicube — Good music deserves to be found. That is why musicube develops revolutionary music search technology. Music streaming services and other companies can forward any user request to musicube and get back high quality data in real time (e.g. to return playlists etc.).
- RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
- HorseAnalytics — HorseAnalytics empowers horse enthusiasts to monitor and improve health and training of horses by applying reliable technologies from health and sports supervision and combining constant and real-time scientific analytics.
We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.
Show more
Investment focus
- Health Care, Software, Information Technology
- Seed, Funding Round, Series A
- Germany, United Kingdom, Finland
Portfolio highlights
- Ovom Care — Enabling every individual to become a parent.
- OroraTech — OroraTech provides global real-time information services. The first target market is early detection and monitoring of wildfires, extended by a proprietary constellation of thermal imaging nanosatellites equipped with in-space AI image processing. At the beginning of 2020, OroraTech launched an MVP called Wildfire Service (WFS) that enables quickdetection and monitoring of wildfires on a global scale. The combination of existing thermal-infrared satellite data with external data layers, such as fuel, wind, and risk maps results in an automatic generation of fire alerts and the display of current fire perimeters for users. The MVP was launched in early 2020 and has gained increasing traction with governmental and large corporate customers all over the world.
- Decade Energy — Decade Energy is the energy infrastructure and optimization partner for transport operators and depot managers who want to electrify their fleets.
Die Brückenköpfe is a management consulting and investing firm focused on the German healthcare market.
Show more
Investment focus
- Artificial Intelligence, Health Care, Life Science
- Seed, Series A, Pre-Seed
- Germany, Austria
Portfolio highlights
- anvajo — Originally started at TU Dresden, anvajo can now look back on several years of innovative research and successful product development with uninterrupted growth. As part of the business expansion and ongoing team building, anvajo moved into its new headquarters in Dresden in January 2020. On 1300 m² practically all areas, including development,production and support functions are united under one roof.
- keleya — Keleya enables women and their partners to have a safe and relaxed pregnancy, birth experience and motherhood by providing them with personalized, expert based information, workouts and nutrition plans and a matching midwife. Founded in 2017, Kelaya is headquartered in Berlin, Germany.
- Recare — Recare developed a software platform for discharge management and supply control in hospitals and other medical facilities. With its B2B marketplace, Recare is trying to end the paperwork in the German healthcare system.
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Show more
Investment focus
- Biotechnology, Software, Health Care
- Funding Round, Series A, Series B
- Germany, India, Kenya
Portfolio highlights
- Uniper — Uniper is an international energy company with about 11,000 employees. They combine a balanced portfolio of technologically advanced large-scale assets with outstanding technical and commercial expertise. Uniper is a German energy company based in Dusseldorf, North Rhine-Westphalia. It was formed by the separation of E.ON's fossil fuel assetsinto a separate company that began operating on 1 January 2016.
- Vectoflow — Vectoflow is an innovative company developing fluid-dynamic metrology devices for fluid flow and dynamics measurement. It offers standardized and customized flow measurement technology that measures the static and total pressure, velocity, and angle of attack of a flow. These products are used in motorsport, aviation, turbine machine development,and research sectors.
- Electrochaea — Electrochaea is commercializing a disruptive, scalable technology to convert electric power into methane, the principal component of natural gas. Using CO2 as a feedstock gas, power can be efficiently converted to renewable natural gas for power storage, for transportation fuels, or for transmission via a natural gas network. The company licensedtechnology from the University of Chicago and is led by the Nidus Partners, a St. Louis investment group specializing in renewable energy. Mich Hein, a Nidus Managing Partner, serves as CEO.Electrochaea has developed a commercially viable and disruptive solution for utility-scale energy storage, grid balancing, and carbon reuse. Their proprietary process converts low-cost and stranded electricity and carbon dioxide into pipeline-grade renewable gas for direct injection into the existing natural gas grid, a conversion process known as “power-to-gas”.
Michael E. Novogratz is the CEO of Galaxy Investment Partners. He was formerly a principal and a member of the board of directors of Fortress Investment Group LLC and Chief Investment Officer of the Fortress Macro Fund. Mr. Novogratz joined Fortress in 2002 after spending 11 years at Goldman Sachs, where he was elected partner in 1998. Mr.Novogratz founded and serves as the Chairman of the Board for Beat the Streets, a non-profit organization which builds wrestling programs in New York City public schools and is also the Honorary Chairman of USA Wrestling Foundation. Mr. Novogratz is Chairman of The Friends of the Hudson River Park. He also serves on the board of the Acumen Fund, NYU Langone Medical Center, Princeton Varsity Club and The Jazz Foundation of America. Mr. Novogratz received an AB from Princeton University in Economics, and served as a helicopter pilot in the US Army.
Show more
Investment focus
- Blockchain, Cryptocurrency, FinTech
- Seed, Funding Round, Series B
- United States, India, Germany
Portfolio highlights
- Portal — The only custody-less interoperability protocol for Bitcoin. Swap native BTC, Ordinals, Runes with L2s and L1s
- Verandah — Verandah is story based conscious luxury resort brand retailing amongst the top 100 in the global luxury resort wear space with design roots strongly based in India. Verandah also has a line of 100% Italian made sustainable swimwear to compliment the season-less ready to wear line.
- Cambrian Biopharma — Cambrian is developing a raft of new companies and therapies to extend healthy lifespan, bringing proven scientific and organizational expertise to exceptional research teams worldwide.
Shine is a venture capital firm that partners with relentless, creative, convincing entrepreneurs from the earliest stages of company building.
Show more
Investment focus
- Software, Blockchain, FinTech
- Seed, Series A, Series B
- United States, Spain, Canada
Portfolio highlights
- 10Beauty — The only 5-step manicure machine in the world.
- iVerify — IVerify is a mobile threat hunting company that provides mobile security solutions for individuals who want to know they can trust their devices with their most sensitive information without sacrificing privacy.
- Mother Games — MOTHER Games is an art and media company that creates transformative experiences through play, blending creativity and innovation to craft unique and engaging interactive experiences.
EQT is a private equity firm that invests in companies and regions where there is an industrial approach.
Show more
Investment focus
- Life Science, Biotechnology, Food and Beverage
- Series A
- Germany
Portfolio highlights
- Formo — We're Formo, the future of dairy. Using micro fermentation, we create animal-free cheeses that humans love.
- Legendairy Foods — We're Formo, the future of dairy. Using micro fermentation, we create animal-free cheeses that humans love.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, United Kingdom, Switzerland
Portfolio highlights
- Enara Bio — Enara Bio is a science-led company targeting the T-cell/cancer cell interface (the “immune synapse”) to develop new targeted cancer immunotherapies designed to treat a broad patient population. Enara Bio focuses on discovering and developing therapeutic cancer vaccines utilizing novel antigens derived from endogenous retroviral (ERV)-relatedDNA sequences.
- PictorLabs — PictorLabs is a digital pathology company advancing AI-powered virtual staining technology to revolutionize histopathology and accelerate clinical research with the goal of improving patient outcomes. Led by a team with deep expertise in bioengineering, artificial intelligence and health-tech product development, the Company is reimagining the ageold practice of histopathology. From a single unstained tissue sample, PictorLabs’ proprietary platform can sustainably produce an unlimited number of virtual stains that are indistinguishable from analogous chemical ones. PictorLabs' technology can replicate standard of care stains and perform specialized virtual biomarker stains for indications that require novel and accelerated diagnostic tests. To learn more, visit https://pictorlabs.ai/ and please follow PictorLabs on LinkedIn.
- Kivu Bioscience — At Kivu Bioscience, we leverage advanced, next-generation proprietary ADC technologies to deliver more precise and effective cancer treatments.
Albert Wenger is a managing partner at Union Square Ventures. Before joining USV, Albert was the president of del.icio.us through the company’s sale to Yahoo and an angel investor (Etsy, Tumblr). He previously founded or co-founded several companies, including a management consulting firm and an early hosted data analytics company. Albert graduatedfrom Harvard College in economics and computer science and holds a Ph.D. in Information Technology from MIT.
Show more
Investment focus
- Software, Analytics, Manufacturing
- Series A, Series B, Seed
- United States, Germany, Egypt
Portfolio highlights
- Brale — Combining the best of CeFi & DeFi.
- Terra.do — Learn about climate change and start working on climate change solutions today with the Terra.do community.
- Unearthly Materials — Unearthly Materials is a transformative materials company focused on delivering practical room-temperature superconductors and powering the century of superconductivity.
1kx is an early-stage investment firm focused on ecosystem growth.
Show more
Investment focus
- Blockchain, Cryptocurrency, Software
- Seed, Funding Round, Series A
- United States, United Kingdom, Germany
Portfolio highlights
- Mawari — Our mission is to unlock new perspectives with real-time immersive technology powered by a decentralized network of global resources
- Predicate — Predicate network simplifies transaction prerequisites.
- Layer — Ethereum is the settlement layer, build full stack decentralized apps on top with Web Assembly and the EVM.
Munich-based AQAL Group is an active technology and impact holding company using the Integral Investing approach. Focus: exponential technology and digital evolution (Internet infrastructure, artificial intelligence, blockchain & financial tech, B2B IT solutions, Industry 4.0), green technology (renewable energy, energy efficiency, cleantech, circular economy), and life in the 21st century (future mobility, food, life science, med tech, media & entertainment tech).
Show more
Investment focus
- Health Care, Medical Device, Biotechnology
- Seed, Pre-Seed
- Germany, United States
Portfolio highlights
- DNTOX — We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
- wondder — Empowering People through Virtual Reality Use our training in Virtual Reality to create more happy, successful, productive teams. Experience the power of wondder. Contact Us Empowering People through Virtual Reality Use our training in Virtual Reality to create more happy,
- Elona Health — Elona Health creates digital solutions that shape tomorrow's psychotherapy and support patients and therapists alike.
Inflection is a first check venture capital firm exploring new frontiers. We run nodes, govern DAOs and write code. We invest between $500k-$1.5M initially and have a global mandate.
Show more
Investment focus
- Blockchain, Cryptocurrency, Software
- Seed, Funding Round, Pre-Seed
- United States, Germany, United Kingdom
Portfolio highlights
- Modulus — Modulus uses cryptography to verify that AI results weren't doctored. It was founded in 2021 and is located in San Francisco, California.
- Lodestar — Lodestar is a next-gen robotics company building a fully-integrated solutions to construct, restore and protect high-value assets in space.
- Fabric Cryptography — Fabric develops a custom cryptography hardware to accelerate cryptography algorithms. The chips, whose components exclusively serve cryptographic purposes, are based on Verifiable Processing Units (VPUs) which incorporate features of GPUs and ASICs to improve the speed and cost of advanced cryptographic workloads.
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Seed, Series A, Pre-Seed
- United States, Germany, United Kingdom
Portfolio highlights
- Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
- ExpressionEdits — Redefining the status quo of protein expression
- Tandem Health — Focus on providing care, while Tandem helps you easily write medical notes directly after the patient consultation.
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, Germany, Belgium
Portfolio highlights
- Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.
- Glox Therapeutics — Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.
- Asgard Therapeutics — Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biologicalproperties of professional antigen-presenting cells.
IBB Ventures is a venture capital and mezzanine arm of Investitionsbank Berlin specializing in seed/startup, early venture, and mid venture investments. The firm invests in technology-oriented companies and companies from the creative industries. It typically invests in information and communication sector with a focus on hardware andsoftware, network technology, new media, and internet and mobile technologies; life science sector with a focus on biotechnology and media technology; and industrial technologies sector with a focus on software, PPS, supply chain management, micro and nanotechnology, environmental and power technology, automation, manufacturing technology, transport technology and logistics, and new materials. The firm also invests in movies, broadcast, television, publisher, music, entertainment, advertising, fashion, design, architecture, multimedia, games, software, and art and culture. It invests in companies based in Berlin. It typically invests between €0.25 million ($0.32 million) and €3 million ($3.83 million) per transaction. The firm prefers to take a board seat in its portfolio companies. IBB Ventures was founded in 1997 and is based in Berlin, Germany.
Show more
Investment focus
- Software, Health Care, Internet
- Seed, Funding Round, Series A
- Germany, United States, United Kingdom
Portfolio highlights
- Vara — Vara develops a breast cancer screening platform powered by AI for radiologists, allowing them to focus on finding cancer early. While we provide. Vara also provides remote mammography reading services to those that lack the radiologists. Vara's mission is to make affordable diagnostics available all over the world by designing machinelearning-powered workflows that users love to work with.
- Nuuron — Nuuron is a neurotech startup that is developing the Memory-Pacemaker, a non-invasive photonic neurostimulation device that allows Alzheimer's sufferers to store and retrieve memories anew.
- Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.
Nico Wittenborn is an Investor at Adjacent.
Show more
Investment focus
- Software, Health Care, Apps
- Seed, Series A, Series B
- United States, Germany, France
Portfolio highlights
- Captions — Say hello to Captions, the only camera and editing app that automatically transcribes, captions and clips your talking videos for you.
- Backbone — Backbone is a mobile gaming controller with intuitive controls, clickable thumbsticks & zero latency that works with cloud and remote gaming.
- Momentum — Finally, a real solution for major gift fundraising. Powered by AI.
Cherry Ventures is an early-stage venture capital firm led by a team of entrepreneurs with experience building fast-scaling companies such as Zalando and Spotify. The firm backs Europe's boldest founders, usually as their first institutional investor, and supports them in everything from their go-to-market strategy and the scaling of theirbusinesses. Cherry Ventures has previously invested in the seed stage of over 50 companies across Europe, including FlixBus, Auto1 Group, Infarm, Rows, Forto, and TourRadar. Cherry Ventures is based in Berlin and invests across Europe with operations in London, Paris, and Stockholm.
Show more
Investment focus
- Software, Financial Services, Information Technology
- Seed, Series A, Series B
- Germany, United Kingdom, United States
Portfolio highlights
- Tola — Tola offers a simple and easy way for businesses to pay and get paid, however and whenever they want. Sign up today!
- Qura — Qura builds AI to make legal text searchable using natural language.
- Atlas Metrics — The single source of truth for your ESG data
Abiomed is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufacture and market products that is designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company's productsare used in the cardiac catheterization lab (cath lab) by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures.
Show more
Investment focus
- Medical Device, Health Care, Medical
- Series B, Series D, Funding Round
- United States, Germany, Israel
Portfolio highlights
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Impulse Dynamics — Impulse Dynamics is a medical device company dedicated to offering innovative solutions for treatment of Chronic Heart Failure (CHF). The Company’s developments are based on its proprietary technology for administering Cardiac Contractility Modulation therapy. This form of treatment has been shown in European clinical trials to produce an immediateand powerful modulating effect on cardiac cells, resulting in clinically meaningful increases incardiac performance.Impulse Dynamics is spearheaded by a team of professionals including, scientists, physicians, and engineers. The Company carries out research programs in major universities and hospitals throughout the world, and is currently engaged in clinical trials in Europe and in the United States. The Optimizer with Cardiac Contractility Modulation therapy, is CE marked. See Clinical Data for more information.
- Shockwave Medical — Shockwave Medical is a Cardiovascular Medical Device Company changing how calcified cardiovascular disease is treated with Intravascular Lithotripsy (IVL).
Healthspan Capital is an early-stage longevity venture capital firm that invests in biotechnology startups developing therapies to slow or reverse aging.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Seed, Funding Round
- Germany, Switzerland, United States
Portfolio highlights
- KetoSwiss — KetoSwiss is a Swiss-based BioTech startup that strives to bring ketone bodies back into the modern world to combat diseases. It develops and clinically tests a novel nutraceutical/medical food for the dietary preventive therapy of higher-frequency migraines and possibly other related neurological diseases characterized by a metabolicdysfunction (such as Alzheimer's disease). KetoSwiss is headquartered at the Technologie Park Basel, in Basel Switzerland, where it is part of a dynamic scientific and entrepreneurial community composed of world-leading academic research laboratories, flourishing life sciences spin-offs and s world-leading biotech-startup-ecosystem.
- ImmuneAGE Bio — ImmuneAGE Bio is the first drug discovery platform company focused on immune system rejuvenation.
- Reservoir Neuroscience — Reservoir Neuroscience is a biopharma company that develops novel therapeutics to repair dysfunctional blood vessels in the brain. Reservoir Neuroscience was founded in 2019 and is based in Emeryville, California.
VF-Funds for innovative and scalable start-ups from the Rhineland Area, Germany
Show more
Investment focus
- Software, Health Care, Manufacturing
- Seed, Series A, Pre-Seed
- Germany, Spain
Portfolio highlights
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- PL BioScience — Animal-free cell culture supplements derived from human platelets. Supporting cell expansion and maintenance from research to therapy.
- Black Semiconductor — Black Semiconductor manufacture microchips with integrated electronic-photonic circuits using graphene technology.
Bool Capital is a private investment firm that builds deep-tech ventures in cloud infrastructure, blockchain, cybersecurity.
Show more
Investment focus
- Life Science, Biotechnology
- Seed
- Germany
Portfolio highlights
- DNTOX — We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
Nimble Ventures invests in innovative companies in technology, healthcare, biotech and genomics, fintech, consumer tech, and blockchain.
Show more
Investment focus
- Software, Biotechnology, Health Care
- Funding Round, Seed, Series A
- United States, Malta, Canada
Portfolio highlights
- Wave Sports + Entertainment — Wave Sports + Entertainment is a media company building brands, original content, talent, and products for the next generation of digital super fans.
- Terradepth — Ocean data faster, greener, and cheaper (ODaaS)
- Lambent — Armored Things enables you to maximize every space to its full potential with crowd intelligence. Optimize operations, minimize security risks, and improve the human experience in your physical spaces.
Dit is de Kitchensink.
Show more
Investment focus
- Biotechnology, Medical Device, Health Care
- Seed, Series A, Funding Round
- The Netherlands, Germany
Portfolio highlights
- Circularise — Circularise brings transparency to global supply chains. Circularise offers different solutions for different problems within the supply chain. Learn how you can become part of the Circular Economy and what solution Circularise can offer your company.
- Corporis Medical — Corporis Medical is a start up focussing on the development and commercialization of innovative medical devices that improve outcomes of surgical interventions. Formerly known as Health Value Creation.
- ReSolved Technologies — ReSolved Technologies are dedicated to increase the circularity of engineering plastics by addressing complex waste streams. They do this by extracting valuable plastics from these difficult-to-recycle waste streams and convert them to recycled material of near-virgin quality that is suited for closed-loop recycling in high-end markets.
KdT Ventures is the standard for early-stage frontier science investing.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Series B
- United States, Israel, Germany
Portfolio highlights
- Marigold Health — Marigold Health is an anonymous social network where people with mental health and substance use conditions support each other.
- Radar Therapeutics — Precision-targeted, smart therapies to conquer the world's most intractable diseases.
- Montara Therapeutics — Montara Therapeutics is a precision-medicine neuroscience biotech startup improving safety and efficacy of therapies for people with neurological diseases
A new tool that blends your everyday work apps into one. It's the all-in-one workspace for you and your team
Show more
Investment focus
- Cryptocurrency, Blockchain, Software
- Pre-Seed, Seed, Private Equity
- United States, Singapore, Spain
Portfolio highlights
- Kiki World — KIKI World is at the heart of this evolution, a virtual-led beauty brand at the intersection of gamified commerce.
- Lumino — Lumino is an AI infrastructure startup whose mission is to enable the power of AI for every human.
- Nest Wallet — Nest Wallet is a wallet created exclusively for traders, and all wallets are linked across mobile and extension.
Think.Health invests as a boutique risk-taker in healthcare ventures. We continuously seek innovations and disruptive business models in digital healthcare, medical technologies and health service providers,
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Seed, Series A, Series B
- Germany, United States, Switzerland
Portfolio highlights
- Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
- Navignostics — Navignostics combines highly multiplex tumor imaging with advanced data analytics for personalized cancer treatments.
- Sphingotec GmbH — Improving patient outcomes with innovative diagnostics for critical care: Actionable insights in real-time
Teknoloji Yatirim is a early-stage technology venture capital & private equity firm.
Show more
Investment focus
- Health Care, Internet, Software
- Seed, Series A
- Turkey, Germany, United States
Portfolio highlights
- Hipporello — Turn your task management platform, Trello or Notion, into a powerful service desk. Manage customer support and ticketing easily. Try now for free!
- Mindsite — Mindsite provides e-commerce analytics. Easily monitor key metrics from price to visibility in real time. Increase your online sales.
- VRLab Academy — VRLab Academy | Virtual Experiments
QIAGEN delivers Sample to Insights solutions that enable customers to unlock insights from the building blocks of life - DNA, RNA and proteins.
Show more
Investment focus
- Biotechnology, Medical, Biopharma
- Seed, Series B, Funding Round
- Germany, United States
Portfolio highlights
- Actome — Actome focuses on developing emulsion coupling technology for life science research and personalized medicine.
- Protagen — Protagen is a precision medicine specialist that support drug development, facilitate treatment strategies and improve patient management. Protagen is at the forefront of immuno-profiling and the discovery of novel autoantibody signatures for autoimmune disease and immuno-oncology. Protagen’s SeroTag® technology identifies biomarkers that address anumber of challenges currently hindering the successful development and broader application of both cancer immunotherapies and novel treatments for autoimmune diseases.The company is a leader in patient stratification for autoimmune disease, having developed disease-specific NavigAID stratification panels that profile individual patient’s autoimmune condition and immune status. This precision medicine approach allows for the development and implementation of more targeted therapies for diseases such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), Sjögren’s syndrome (SjS) and others.
- Coley Pharmaceutical Group — Coley Pharmaceutical Group operates as a biopharmaceutical company developing therapeutics and drug candidates that direct the human immune system to fight cancers, asthma and allergy, autoimmune disorders, and to enhance the effectiveness of vaccines. The company was formerly known as CpG ImmunoPharmaceuticals, Inc. and in August 2000 it changedits name to Coley Pharmaceutical Group, Inc. The company was founded in 1997 and is based in Wellesley, Massachusetts. As of December 28, 2007, Coley Pharmaceutical Group, Inc. operates as a subsidiary of Pfizer Inc.
Iduskia
Show more
Investment focus
- News, Life Science, Social Media
- Seed
- Germany
Portfolio highlights
- Labiotech.eu — Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News!
b.value AG are into Biotechnology investments.
Show more
Investment focus
- Biotechnology, Military, Textiles
- Seed, Pre-Seed, Funding Round
- Germany
Portfolio highlights
- Revoltech — Developer of textile technology intended to transform the way material is made. Revoltech‘s first product is LOVR: the world's first plastic-free and 100% plant-based leather alternative made of agricultural residues.
- FibreCoat — Making the future affordable. EM-Shielding Composites Sustainable https://fibrecoat.de/wp-content/uploads/2022/01/20211004_FibreCoat_web.mp4 Shedule a meeting to solve your problem Mobility Affordable and damage-resistant materials for integrated EMI-shielding and weight reduction in EVs. Construction Easy retrofit shielding of electronics and people from 5G and other types of EM radiation. Government Specialized yarns for sensors, circuits, shielding and countermeasure materials. With
- Cultimate Foods — Cultimate Foods is a cellular agriculture company. It develops cultivated fat for hybrid alt-meat products. It's cultivated fat replicates the structure of animal fat tissue and it uses a "unique technological approach to 3D cultivation that creates the structure of their ingredient and reduces production costs."
hiVC is an early-stage venture capital that connects early-stage startups with winning business models to achieve global success.
Show more
Investment focus
- Education, Life Science, Food Delivery
- Pre-Seed, Series A
- Turkey, Germany
Portfolio highlights
- VRLab Academy — VRLab Academy | Virtual Experiments
- Mizanplus Kitchens — Mizanplus Kitchens provides delivery service multi-brand dark store network.
Early stage investor in techbio
Show more
Investment focus
- Software, Blockchain, Health Care
- Seed, Pre-Seed
- Germany, United States
Portfolio highlights
- ReSync Bio — ReSync Bio is a scientific software firm that develops solutions to help biopharmaceutical companies accelerate their drug discovery processes.
- Molecule — Molecule is a collaborative platform, where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients. We connect leading researchers to investment opportunities by turning intellectual property and its development into a liquid and easily investable asset.
BACKED is the human-centric venture capital fund. We invest in exceptional founders at Seed in Europe. Welcome to Different.
Show more
Investment focus
- Software, Blockchain, Enterprise Software
- Seed, Series A, Funding Round
- United Kingdom, United States, The Netherlands
Portfolio highlights
- Lopay — Lopay gives you more control, more flexibility, and instant access to the money you earn.
- 0G Labs — The First Decentralized AI Operating System
- Smart Transactions — Smart Transactions is a protocol designed to execute transactions.
Chorus One is offering staking services and building tools and protocols to advance the Proof of Stake ecosystem.
Show more
Investment focus
- Blockchain, Software, Cryptocurrency
- Seed, Funding Round, Series A
- United States, Canada, Singapore
Portfolio highlights
- IDA — IDA is the leading provider of digital asset solutions, allowing trust, transparency, and speed in payments and commerce. By leveraging blockchain technology, IDA opens up a more connected and inclusive global economy.
- Chainbound — Chainbound is a research and development organization building optimized infrastructure and networking tools for blockchains. We are hiring!
- Amnis Finance — Amnis Finance is a staking technology built on the Aptos blockchain. It is the game-changing liquid staking solution that offers a simple way to earn rewards on your APT tokens. By staking with Amnis, your tokens remain liquid and may be utilized in a variety of DeFi applications, earning additional incentives.
Seed Fonds has a strong competence network with national and international investors, business angels & expertes from the industry. They are specialized in the development of comprehensive financing models offering stability and development opportunities on the long term.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Funding Round, Seed, Series A
- Germany
Portfolio highlights
- miacosa — miacosa.de is operated by the Endorsed Goods GmbH. miacosa.de is a social shopping concept from Germany based in Cologne. Social Shopping the miacosa way means that members select their personal shopping team of experts and celebrities that present products they love on miacosa.de Miacosa is for members only. The free service starts with productsfrom the fields of Health Style, Home & Living, Kitchen and fashion accessories.
- Hemovent — Based in Aachen, Germany, Hemovent is a privately held medical technology company that is developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. Hemovent was founded by serial entrepreneur, Christof Lenz and Oliver Marseille, inventors of the company’s proprietary platform. It is the goal of the company to develop aninnovative solution, with precision and craftsmanship, that will aide patients with lung and heart function while allowing them to be mobile.
- aquila biolabs — aquila biolabs is a German technology company focusing on the development of innovative laboratory devices for the analysis of shake-flask fermentations in biotechnological, chemical and pharmaceutical research and development.
Investors by industry
Health Care
Google
Gaming
Climate
Energy
Community
Marketplace
Hardware
Biotech
Consumer
Proptech
Artificial intelligence
FinTech
Impact
EdTech
Sustainability
Venture Capital
Fashion
Big Data
Finance
Web3
B2B
Beauty
Retail
Education
Clean Energy
Oil and Gas
Food and Beverage
Real Estate
Video Games
Payments
Infrastructure
Photography
Financial Services
Organic Food
Publishing
Social Media
Social Network
Wellness
Enterprise Software
Medical
Android
Digital Media
Music
Legal
Franchise
Local
Internet
Construction
Sports
eSports
Manufacturing
Email
Mobile
Art
Hospitality
Biotechnology
Travel
Fitness
Recruiting
Platforms
Cannabis
Mobile Advertising
Medical Device
Automotive
Wine And Spirits
Crowdfunding
Social
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
LGBT
Theatre
Film
Life Science
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
Germany
United Kingdom
India
Canada
South Korea
Australia
Ireland
New Zealand
United States
Africa
Vietnam
Saudi Arabia
Japan
South Africa
Europe
Oceania
LATAM
Indonesia
Middle East
Asia
Sri Lanka
China
Singapore
Brazil
Armenia
Qatar
Spain
Chile
Belgium
France
Belarus
Egypt
Ghana
Croatia
Ethiopia
Costa Rica
Gibraltar
Greece
Finland
Kenya
Lithuania
Liechtenstein
Panama
Myanmar
Lebanon
Cayman Islands
Mexico
Philippines
Mali
Norway
Malta
Israel
Italy
Kazakhstan
Cambodia
Peru
Kuwait
Malaysia
Nicaragua
Liberia
Mauritius
Morocco
Jersey
Slovenia
Thailand
Uzbekistan
Serbia
Zimbabwe
Sierra Leone
Zambia
Venezuela
Taiwan
Togo
Portugal
Turkey
Seychelles
San Marino
Uganda
Rwanda
Uruguay
Ukraine
Sweden
Senegal
Tanzania
Tunisia
Russian Federation
El Salvador
Poland
Puerto Rico
Tajikistan
Dominican Republic
Iraq
Bahamas
Azerbaijan
Nigeria
Iceland
Namibia
United Arab Emirates
Honduras
Bolivia
Isle of Man
Luxembourg
Belize
Denmark
Pakistan
Albania
Hong Kong
Barbados
Bahrain
Hungary
Argentina
Jordan
Bangladesh
Grenada
Romania
Georgia
Bermuda
Czech Republic
Ecuador
Bulgaria
Algeria
Estonia
Faroe Islands
Oman
Cyprus
Latvia
Cameroon
Austria
Switzerland
Colombia
Guatemala
Marshall Islands
Investors in Germany by industry
Enterprise
Biotech
Health Care
Consumer
Climate
EdTech
Impact
Marketplace
SaaS
Community
Hardware
Energy
Gaming
Crowdfunding
Venture Capital
Real Estate
Fashion
Transportation
Education
Financial Services
Cryptocurrency
Restaurants
Finance
Payments
Food and Beverage
Wine And Spirits
Video Games
Organic Food
Publishing
Medical
Email
Digital Media
Medical Device
Wellness
Social Media
Music
Manufacturing
Art
Blockchain
Android
Mobile
Social Impact
Software
Social Network
Construction
Local
Legal
Sports
Enterprise Software
eSports
Fitness
Travel
Hospitality
InsurTech
Automotive
Mobile Advertising
Platforms
Cannabis
Mobile Apps
Retail
Infrastructure
Beauty
Web3
B2B
Life Science
Big Data
Photography
Renewable Energy
Clean Energy
Recruiting
Internet
Franchise
Sustainability
Oil and Gas
Proptech
Artificial intelligence
Biotechnology
Social
Sporting Goods
Agriculture (agtech)
Media (entertainment)
FinTech
CleanTech